Therapeutic Solutions International, Inc. engages in the provision of immune modulation for the treatment of several specific diseases. The firm is also involved in developing a range of immune-modulatory agents to target certain cancers, schizophrenia, suicidal ideation, traumatic brain injury, and for daily health. The company was founded on August 6, 2007 and is headquartered in Elk, ID.
Sector:
Health Technology
Industry:
Pharmaceuticals Other
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Therapeutic Solutions International Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Therapeutic Solutions International Inc market cap is $512,300.00.
What is the 52-week high for Therapeutic Solutions International Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Therapeutic Solutions International Inc 52 week high is $0.0009 as of September 11, 2025.
What is the 52-week low for Therapeutic Solutions International Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Therapeutic Solutions International Inc 52 week low is $0.00 as of September 11, 2025.
What is Therapeutic Solutions International Inc stock price today?
Therapeutic Solutions International Inc stock price today is $0.0001.
What was Therapeutic Solutions International Inc stock price yesterday?
Therapeutic Solutions International Inc stock price yesterday was $0.0001.
What is the PE ratio of Therapeutic Solutions International Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Therapeutic Solutions International Inc’s P/E ratio is -0.17.
What is the Price-to-Book ratio of Therapeutic Solutions International Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Therapeutic Solutions International Inc P/B ratio is 0.4.
What is the 50-day moving average of Therapeutic Solutions International Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Therapeutic Solutions International Inc 50-day moving average is $0.0001.